Weimin Xia
Shanghai Jiao Tong University(CN)XinHua Hospital(CN)
Publications by Year
Research Areas
Bladder and Urothelial Cancer Treatments, Cancer Immunotherapy and Biomarkers, Ferroptosis and cancer prognosis, Acute Kidney Injury Research, Immune Cell Function and Interaction
Most-Cited Works
- → Predictable Roles of Peripheral IgM Memory B Cells for the Responses to Anti-PD-1 Monotherapy Against Advanced Non-Small Cell Lung Cancer(2021)43 cited
- → Peripheral CD4+ T cell signatures in predicting the responses to anti-PD-1/PD-L1 monotherapy for Chinese advanced non-small cell lung cancer(2021)31 cited
- → NLRP4 negatively regulates type I interferon response and influences the outcome in anti‐programmed cell death protein (PD)‐1/PD‐ligand 1 therapy(2021)21 cited
- → LRRK2 aggravates kidney injury through promoting MFN2 degradation and abnormal mitochondrial integrity(2023)21 cited
- Significance of serum neuron-specific enolase in patients with acute traumatic brain injury.(2003)
- → Revealing prognostic and tumor microenvironment characteristics of cuproptosis in bladder cancer by genomic analysis(2022)15 cited
- → The combination therapy of Everolimus and anti-PD-1 improves the antitumor effect by regulating CD8+ T cells in bladder cancer(2022)9 cited
- → Novel Ferroptosis-Related Multigene Prognostic Models for Patients with Bladder Cancer(2021)7 cited
- → Correlation of prostatic morphological parameters and clinical progression in aging Chinese men with benign prostatic hyperplasia: Results from a cross‐sectional study(2021)7 cited
- → Urinary kidney injury molecule-1: a novel biomarker to monitor renal function in patients with unilateral ureteral obstruction(2020)6 cited